|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
154.64(B) |
Last
Volume: |
7,454,805 |
Avg
Vol: |
7,968,223 |
52
Week Range: |
$81.6 - $107.76 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 39 |
Guru Rank Value : 15.1 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
50 |
50 |
Total Buy Value |
$0 |
$0 |
$4,515 |
$4,515 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
174,214 |
764,278 |
1,524,600 |
2,651,364 |
Total Sell Value |
$18,397,419 |
$78,667,727 |
$147,564,974 |
$221,205,216 |
Total People Sold |
4 |
7 |
12 |
14 |
Total Sell Transactions |
6 |
16 |
50 |
92 |
End Date |
2025-06-08 |
2025-03-07 |
2024-09-06 |
2023-09-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-09-02 |
4 |
AS |
$104.89 |
$5,271,416 |
D/D |
(50,000) |
178,342 |
|
1% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-09-02 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
Monson Jonathan |
EVP and CFO |
|
2025-08-02 |
4 |
D |
$105.41 |
$55,656 |
D/D |
(528) |
35,289 |
|
- |
|
Monson Jonathan |
EVP and CFO |
|
2025-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,090 |
35,817 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2025-08-01 |
4 |
AS |
$104.63 |
$1,811,520 |
D/D |
(17,313) |
23,600 |
|
2% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2025-08-01 |
4 |
OE |
$17.26 |
$429,493 |
D/D |
17,313 |
40,913 |
|
- |
|
Ludwig Edward J |
Director |
|
2025-08-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
17,979 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-08-01 |
4 |
AS |
$104.63 |
$5,231,670 |
D/D |
(50,000) |
178,342 |
|
2% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-08-01 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
Fujimori Yoshiaki |
Director |
|
2025-07-29 |
4 |
S |
$106.99 |
$310,378 |
D/D |
(2,901) |
2,081 |
|
-1% |
|
Ludwig Edward J |
Director |
|
2025-07-25 |
4 |
S |
$106.03 |
$424,120 |
D/D |
(4,000) |
18,479 |
|
-1% |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2025-07-01 |
4 |
D |
$104.78 |
$204,531 |
D/D |
(1,952) |
33,451 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2025-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,036 |
35,403 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-07-01 |
4 |
AS |
$106.97 |
$5,348,315 |
D/D |
(50,000) |
178,342 |
|
2% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-07-01 |
4 |
OE |
$26.15 |
$1,307,500 |
D/D |
50,000 |
228,342 |
|
- |
|
Monson Jonathan |
EVP and CFOOfficer |
|
2025-06-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,727 |
|
-0% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-06-04 |
4 |
AS |
$102.88 |
$5,799,630 |
D/D |
(56,372) |
178,342 |
|
5% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2025-06-04 |
4 |
OE |
$26.15 |
$1,474,128 |
D/D |
56,372 |
234,714 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2025-06-02 |
4 |
AS |
$103.39 |
$17,051,136 |
D/D |
(164,443) |
1,476,882 |
|
3% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2025-06-02 |
4 |
OE |
$17.26 |
$2,183,161 |
D/D |
105,619 |
1,641,325 |
|
- |
|
Ludwig Edward J |
Director |
|
2025-05-29 |
4 |
S |
$104.59 |
$418,368 |
D/D |
(4,000) |
22,479 |
|
-3% |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2025-05-21 |
4 |
AS |
$106.42 |
$513,583 |
D/D |
(4,826) |
31,367 |
|
2% |
|
Wichmann David S |
Director |
|
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,081 |
41,582 |
|
- |
|
Morano Susan E |
Director |
|
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,686 |
6,639 |
|
- |
|
Sununu John E |
Director |
|
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,081 |
54,723 |
|
- |
|
2527 Records found
|
|
Page 1 of 102 |
|
|